Max Levin

3.1k total citations
56 papers, 1.8k citations indexed

About

Max Levin is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Max Levin has authored 56 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Immunology and 12 papers in Oncology. Recurrent topics in Max Levin's work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (8 papers) and Atherosclerosis and Cardiovascular Diseases (7 papers). Max Levin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (8 papers) and Atherosclerosis and Cardiovascular Diseases (7 papers). Max Levin collaborates with scholars based in Sweden, United States and Germany. Max Levin's co-authors include Tom Björnheden, Olov Wiklund, Lillemor Mattsson Hultén, Jan Borén, Marcus Ståhlman, Lars Ny, Jens Nielsen, Francesco Gatto, Olli Leppänen and Masaomi Nangaku and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Max Levin

53 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Levin Sweden 21 914 337 335 321 301 56 1.8k
Sinéad Toomey Ireland 19 714 0.8× 231 0.7× 202 0.6× 494 1.5× 243 0.8× 66 2.0k
Zhongmin Liu China 24 935 1.0× 425 1.3× 163 0.5× 230 0.7× 362 1.2× 66 2.0k
Christine Lohmann Switzerland 23 555 0.6× 604 1.8× 295 0.9× 248 0.8× 174 0.6× 32 2.0k
Baoheng Du United States 24 1.0k 1.1× 285 0.8× 234 0.7× 686 2.1× 579 1.9× 30 2.6k
Zheng‐Gen Jin United States 22 1.8k 2.0× 590 1.8× 378 1.1× 303 0.9× 291 1.0× 29 2.8k
Tong Yin China 25 1.1k 1.2× 379 1.1× 164 0.5× 417 1.3× 194 0.6× 102 3.1k
Toshiyuki Kita Japan 24 624 0.7× 327 1.0× 341 1.0× 298 0.9× 227 0.8× 127 2.1k
Qun Dai United States 22 1.0k 1.1× 246 0.7× 149 0.4× 285 0.9× 257 0.9× 61 2.1k
Mahrukh K. Ganapathi United States 27 1.3k 1.5× 374 1.1× 158 0.5× 590 1.8× 320 1.1× 67 2.4k
Shinya Abe Japan 23 718 0.8× 156 0.5× 400 1.2× 239 0.7× 135 0.4× 90 1.9k

Countries citing papers authored by Max Levin

Since Specialization
Citations

This map shows the geographic impact of Max Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Levin more than expected).

Fields of papers citing papers by Max Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Levin. The network helps show where Max Levin may publish in the future.

Co-authorship network of co-authors of Max Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Max Levin. A scholar is included among the top collaborators of Max Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Levin. Max Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Carow, Berit, Kristina Skålén, Chika Yokota, et al.. (2024). Immune mapping of human tuberculosis and sarcoidosis lung granulomas. Frontiers in Immunology. 14. 1332733–1332733. 9 indexed citations
3.
Mortier, Laurent, Lisa Villabona, Ben Lawrence, et al.. (2024). Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study. American Journal of Clinical Dermatology. 25(6). 987–996. 3 indexed citations
4.
Cinato, Mathieu, Marion Laudette, Entela Bollano, et al.. (2023). Cardiac Plin5 interacts with SERCA2 and promotes calcium handling and cardiomyocyte contractility. Life Science Alliance. 6(4). e202201690–e202201690. 7 indexed citations
5.
Bratulić, Siniša, Angelo Limeta, Francesca Maccari, et al.. (2022). Analysis of normal levels of free glycosaminoglycans in urine and plasma in adults. Journal of Biological Chemistry. 298(2). 101575–101575. 17 indexed citations
6.
Johansson, Iva, Max Levin, Levent M. Akyürek, Roger Olofsson Bagge, & Lars Ny. (2021). PD‐1 inhibitor therapy of basal cell carcinoma with pulmonary metastasis. Journal of the European Academy of Dermatology and Venereology. 36(S1). 70–73. 3 indexed citations
7.
Gatto, Francesco, Siniša Bratulić, Ilaria T. Cavarretta, et al.. (2021). Detection of any-stage cancer using plasma and urine glycosaminoglycans.. Journal of Clinical Oncology. 39(15_suppl). 3034–3034. 5 indexed citations
8.
Limeta, Angelo, Boyang Ji, Max Levin, Francesco Gatto, & Jens Nielsen. (2020). Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma. JCI Insight. 5(23). 106 indexed citations
9.
Jespersen, Henrik, Roger Olofsson Bagge, Gustav Ullenhag, et al.. (2019). Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study. BMC Cancer. 19(1). 415–415. 52 indexed citations
10.
Filges, Stefan, et al.. (2019). Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma. Case Reports in Oncology. 12(3). 872–879. 6 indexed citations
11.
Andersson, Linda, Knut Tomas Dalen, Marcus Ståhlman, et al.. (2017). Deficiency in perilipin 5 reduces mitochondrial function and membrane depolarization in mouse hearts. The International Journal of Biochemistry & Cell Biology. 91. 9–13. 20 indexed citations
12.
Ekstrand, Matias, Levent M. Akyürek, Martin Johansson, et al.. (2017). Depletion of ATP and glucose in advanced human atherosclerotic plaques. PLoS ONE. 12(6). e0178877–e0178877. 20 indexed citations
13.
Andersson, Linda, Margareta Scharin Täng, Annika Lundqvist, et al.. (2015). Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia. Cardiovascular Research. 107(4). 478–486. 14 indexed citations
14.
Ekstrand, Matias, Maria Trajkovska, Per Fogelstrand, et al.. (2015). Imaging of Intracellular and Extracellular ROS Levels in Atherosclerotic Mouse Aortas Ex Vivo: Effects of Lipid Lowering by Diet or Atorvastatin. PLoS ONE. 10(6). e0130898–e0130898. 34 indexed citations
15.
Friederich‐Persson, Malou, et al.. (2013). Kidney Hypoxia, Attributable to Increased Oxygen Consumption, Induces Nephropathy Independently of Hyperglycemia and Oxidative Stress. Hypertension. 62(5). 914–919. 138 indexed citations
16.
Khorram‐Manesh, Amir, et al.. (2009). Nuclear expression of μ‐opioid receptors in a human mesothelial cell line. Autonomic and Autacoid Pharmacology. 29(4). 165–170. 5 indexed citations
17.
Bräsen, Jan Hinrich, Olli Leppänen, Matias Inkala, et al.. (2007). Extracellular Superoxide Dismutase Accelerates Endothelial Recovery and Inhibits In-Stent Restenosis in Stented Atherosclerotic Watanabe Heritable Hyperlipidemic Rabbit Aorta. Journal of the American College of Cardiology. 50(23). 2249–2253. 41 indexed citations
18.
Leppänen, Olli, et al.. (2006). ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo. Atherosclerosis. 188(2). 323–330. 81 indexed citations
19.
Mostov, Keith E., Paul Brakeman, Anirban Datta, et al.. (2005). Formation of Multicellular Epithelial Structures. Novartis Foundation symposium. 269. 193–205. 8 indexed citations
20.
Levin, Max, S Seidner, Bradley A. Yoder, et al.. (2005). Postnatal constriction, ATP depletion, and cell death in the mature and immature ductus arteriosus. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 290(2). R359–R364. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sinéad Toomey Breakdown of academic impact, for papers by Zhongmin Liu Breakdown of academic impact, for papers by Christine Lohmann Breakdown of academic impact, for papers by Baoheng Du Breakdown of academic impact, for papers by Zheng‐Gen Jin Breakdown of academic impact, for papers by Tong Yin Breakdown of academic impact, for papers by Toshiyuki Kita Breakdown of academic impact, for papers by Qun Dai Breakdown of academic impact, for papers by Mahrukh K. Ganapathi Breakdown of academic impact, for papers by Shinya Abe
Rankless by CCL
2026